BRCA1 gene mutation

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
M Musculoskeletal (ATC M) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Verein Zur Praevention Und Therapie Boesartiger Erkrankungen Austrian Breast And Colorectal Cancer Study Group Academic
    DENOSUMAB
    2024-513734-38-00 3 countries 2019 n=1,150
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Verein Zur Praevention Und Therapie Boesartiger Erkrankungen Austrian Breast And Colorectal Cancer Study Group Academic 1 Phase III 1
New trials by year
2019
1
← All indication landscapes